Skip to main content
Back
Watch Compare

Universe Pharmaceuticals INC

Data quality: 100%
UPC
Nasdaq Manufacturing Chemicals
$2.95
▼ $0.20 (-6.35%)
Mkt Cap: 1.66 M
Price
$2.95
Mkt Cap
1.66 M
Day Range
$2.86 — $3.16
52-Week Range
$2.00 — $11.00
Volume
3,200
Open $3.16
50D / 200D Avg
$3.08
4.31% below
50D / 200D Avg
$3.86
23.58% below

Quick Summary

Key Takeaways

Revenue grew 339.23% annually over 5 years — strong growth
Debt/Equity of 0.05 — conservative balance sheet
Negative free cash flow of -5.32 B
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 77124.95%
Capital efficient — spends only 1.49% of revenue on capex

Growth

Revenue Growth (5Y)
339.23%
Above sector avg (9.35%)
Revenue (1Y)77464.18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-9941.84%
Below sector avg (-51.02%)
ROIC-5659.17%
Net Margin-20.56%
Op. Margin-16.33%

Safety

Debt / Equity
0.05
Below sector avg (0.33)
Current Ratio1.63
Interest Coverage-10.08

Valuation

PE (TTM)
0.00
Above sector avg (-1.98)
P/B Ratio0.06
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E 0.0 -2.0
P/B 0.1 5.1
ROE % -9941.8 -51.0
Net Margin % -20.6 -150.2
Rev Growth 5Y % 339.2 9.3
D/E 0.1 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 77464.18% Revenue Growth (3Y) 2009.21%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 339.23% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 17.86 B Net Income (TTM) -3.67 B
ROE -9941.84% ROA -6130.34%
Gross Margin 35.28% Operating Margin -16.33%
Net Margin -20.56% Free Cash Flow (TTM) -5.32 B
ROIC -5659.17% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.05 Current Ratio 1.63
Interest Coverage -10.08 Asset Turnover 298.14
Working Capital 12.92 M Tangible Book Value 26.60 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 0.00 Forward P/E N/A
P/B Ratio 0.06 P/S Ratio 0.00
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -320070.98%
Market Cap 1.66 M Enterprise Value 3.05 M
Per Share
EPS (Diluted TTM) -8.06 Revenue / Share 31701.68
FCF / Share -9442.11 OCF / Share -8968.56
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.49% FCF Conversion 144.85%
SBC-Adj. FCF N/A Growth Momentum 77124.95

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2023 FY2021
Revenue 17.86 B 23.02 M 40.14 M 32.31 M 47.98 M
Net Income -3.67 B -8.73 M -8.74 M -6.16 M 11.32 M
EPS (Diluted) -8.06 -626.96 -0.40 -1.70 —
Gross Profit 6.30 B 6.07 M 21.89 M 10.32 M 25.33 M
Operating Income -2.92 B -8.02 M — -3.53 M 13.59 M
EBITDA — — — — —
R&D Expenses 671.76 M 3.03 M 7.64 M 4.86 M 5.47 M
SG&A Expenses — — — — —
D&A 517.43 M 485,734.0 533,949.0 508,785.0 446,878.0
Interest Expense 289.39 M 278,172.0 162,400.0 156,788.0 101,604.0
Income Tax 606.70 M 606,704.0 752,419.0 2.31 M 2.36 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2023 FY2021
Total Assets 69.30 B 67.95 M 59.54 M 53.29 M 70.14 M
Total Liabilities 13.17 B 22.45 M — — —
Shareholders' Equity 56.13 B 45.50 M 46.44 M 39.53 M 58.93 M
Total Debt 7.15 B 5.86 M 3.94 M 1.37 M 4.33 M
Cash & Equivalents — — — — 8.08 M
Current Assets 53.60 B 51.64 M 41.51 M 36.81 M 50.48 M
Current Liabilities 13.17 B 20.31 M 13.10 M 13.75 M 11.21 M